Copyright
©The Author(s) 2024.
World J Stem Cells. Dec 26, 2024; 16(12): 1062-1085
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1062
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1062
Table 1 The top 10 countries/regions and institutions in the field of mesenchymal stem cell therapy for atherosclerosis
Rank | Country/region | Documents | Citations | Institution | Documents | Centrality |
1 | China | 195 | 4797 | Zhejiang University | 16 | 0.19 |
2 | United States | 140 | 9989 | University of London | 14 | 0.03 |
3 | United Kingdom | 36 | 2778 | Harvard University | 12 | 0.13 |
4 | Japan | 32 | 1071 | Shanghai Jiao Tong University | 11 | 0.05 |
5 | Italy | 31 | 1584 | King’s College London | 11 | 0.02 |
6 | Germany | 27 | 1251 | Sun Yat Sen University | 10 | 0.04 |
7 | Canada | 17 | 524 | Harvard Medical School | 9 | 0.09 |
8 | Korea | 17 | 231 | Institut National de la Sante et de la Recherche Medicale (Inserm) | 9 | 0.07 |
9 | Australia | 16 | 667 | University of California System | 9 | 0.07 |
10 | France | 15 | 1553 | Chinese Academy of Sciences | 9 | 0.04 |
Table 2 The top 10 journals and co-cited journals in the field of mesenchymal stem cell therapy for atherosclerosis
Rank | Journal | Documents | Citations | JCR (2023) | Co-cited journal | Citations | JCR (2023) |
1 | Int J Mol Sci | 16 | 227 | Q1, 5.6 | Circulation | 1772 | Q1, 37.8 |
2 | Front Cardiovasc Med | 15 | 341 | Q2, 3.6 | Circ Res | 1690 | Q1, 20.1 |
3 | Stem Cell Res Ther | 13 | 288 | Q1, 7.5 | Arterioscl Throm Vas | 1347 | Q1, 8.7 |
4 | Arterioscl Throm Vas | 10 | 699 | Q1, 8.7 | P Natl Acad Sci Usa | 812 | Q1, 11.1 |
5 | Cells-Basel | 9 | 81 | Q2, 6 | J Biol Chem | 809 | Q2, 4.8 |
6 | Circ Res | 9 | 1348 | Q1, 20.1 | Nature | 743 | Q1, 64.8 |
7 | Plos One | 9 | 209 | Q2, 3.7 | Plos One | 724 | Q2, 3.7 |
8 | Cardiovasc Res | 8 | 347 | Q1, 10.9 | J Clin Invest | 684 | Q1, 15.9 |
9 | Atherosclerosis | 7 | 275 | Q2, 5.3 | Science | 530 | Q1, 56.9 |
10 | Biochem Bioph Res Co | 6 | 270 | Q3, 3.1 | Cardiovasc Res | 520 | Q1, 10.9 |
Table 3 The top 10 authors and co-cited authors in the field of mesenchymal stem cell therapy for atherosclerosis
Rank | Author | Documents | Cited author | Documents | Centrality |
1 | Xu Qingbo | 9 | Libby P | 84 | 0.08 |
2 | Orekhov Alexander N | 5 | Ross R | 54 | 0.16 |
3 | Li Song | 4 | Wang Y | 49 | 0.04 |
4 | Li Mincai | 4 | Asahara T | 48 | 0.19 |
5 | Colmegna Ines | 3 | Pittenger MF | 48 | 0.04 |
6 | Broskey Nicholas T | 3 | Hu YH | 41 | 0.06 |
7 | Zhang Wei | 3 | Zhang Y | 40 | 0.05 |
8 | Houmard Joseph A | 3 | Li Q | 37 | 0.03 |
9 | Song Chunli | 3 | Liu Y | 36 | 0.1 |
10 | Yu Jun | 3 | Sata M | 36 | 0.07 |
Table 4 The top 10 publications in the field of mesenchymal stem cell therapy for atherosclerosis
Rank | Title | Journal | Citations | Type | Year | Ref. |
1 | Vascular smooth muscle cells in atherosclerosis | Nat Rev Cardiol | 887 | Review | 2019 | [83] |
2 | KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis | Nat Med | 726 | Article | 2015 | [84] |
3 | Mechanobiology of YAP and TAZ in physiology and disease | Nat Rev Mol Cell Biol | 710 | Review | 2017 | [85] |
4 | Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease | Annu Rev Physiol | 537 | Review | 2012 | [86] |
5 | Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche | Histol Histopathol | 451 | Review | 2009 | [87] |
6 | Gold nanoparticles for photoacoustic imaging | Nanomedicine (Lond) | 417 | Review | 2015 | [88] |
7 | Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands | Immunity | 368 | Article | 2011 | [89] |
8 | Biomedical applications of photoacoustic imaging with exogenous contrast agents | Ann Biomed Eng | 306 | Review | 2012 | [90] |
9 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling | Mediators Inflamm | 300 | Review | 2013 | [91] |
10 | Physical and mechanical regulation of macrophage phenotype and function | Cell Mol Life Sci | 296 | Review | 2015 | [92] |
Table 5 The top 10 co-cited references in the field of mesenchymal stem cell therapy for atherosclerosis
Rank | Title | Journal | Citations | Type | Year | Ref. |
1 | Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE(-/-) mice via miR-let7 mediated infiltration and polarization of M2 macrophage | Biochem Biophys Res Commun | 26 | Article | 2019 | [93] |
2 | Vascular smooth muscle cells in atherosclerosis | Nat Rev Cardiol | 22 | Review | 2019 | [83] |
3 | Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease | Cell Stem Cell | 21 | Article | 2016 | [94] |
4 | Mesenchymal stem cells reduce murine atherosclerosis development | Sci Rep | 16 | Article | 2015 | [65] |
5 | Shedding light on the cell biology of extracellular vesicles | Nat Rev Mol Cell Biol | 14 | Review | 2018 | [95] |
6 | Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | J Extracell Vesicles | 14 | Guidelines | 2018 | [96] |
7 | Extensive proliferation of a subset of differentiated, yet plastic, medial vascular smooth muscle cells contributes to neointimal formation in mouse injury and atherosclerosis models | Circ Res | 13 | Article | 2016 | [97] |
8 | Vascular smooth muscle cells in atherosclerosis | Circ Res | 13 | Review | 2016 | [98] |
9 | Human gingiva-derived mesenchymal stem cells modulate monocytes/macrophages and alleviate atherosclerosis | Front Immunol | 13 | Article | 2018 | [66] |
10 | Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction | Theranostics | 12 | Article | 2018 | [99] |
11 | Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness | Cardiovasc Res | 12 | Review | 2018 | [100] |
12 | Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice | Cardiovasc Res | 12 | Article | 2019 | [101] |
13 | Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19 | Cardiovasc Res | 12 | Article | 2020 | [102] |
Table 6 The top 25 keywords in the field of mesenchymal stem cell therapy for atherosclerosis
Rank | Keywords | Counts | Centrality | Year |
1 | Mesenchymal stem cells | 260 | 0.11 | 2004 |
2 | Atherosclerosis | 132 | 0.1 | 1999 |
3 | Smooth muscle cells | 96 | 0.15 | 2003 |
4 | Expression | 86 | 0.04 | 2007 |
5 | Stem cells | 72 | 0.05 | 2004 |
6 | Progenitor cells | 64 | 0.06 | 2007 |
7 | Endothelial cells | 63 | 0.05 | 2005 |
8 | Differentiation | 58 | 0.06 | 1999 |
9 | In vitro | 52 | 0.05 | 2004 |
10 | Myocardial infarction | 52 | 0.06 | 2004 |
11 | Inflammation | 52 | 0.03 | 2010 |
12 | Bone marrow | 51 | 0.07 | 2003 |
13 | Endothelial progenitor cells | 48 | 0.05 | 2004 |
14 | Stromal cells | 48 | 0.1 | 2004 |
15 | Oxidative stress | 45 | 0.03 | 2010 |
16 | Proliferation | 42 | 0.04 | 2005 |
17 | Cardiovascular disease | 39 | 0.07 | 2004 |
18 | Disease | 37 | 0.01 | 2009 |
19 | Mechanisms | 36 | 0.05 | 2007 |
20 | Extracellular vesicles | 34 | 0.02 | 2016 |
21 | In vivo | 32 | 0.01 | 2009 |
22 | Vascular calcification | 31 | 0.02 | 2004 |
23 | Angiogenesis | 30 | 0.08 | 2003 |
24 | Gene expression | 28 | 0.02 | 2009 |
25 | Activation | 28 | 0.02 | 2012 |
- Citation: Cheng X, Li YL, Wang H, Zhang RJ, Fan KY, Qi XT, Zheng GP, Dong HL. Mesenchymal stem cell therapy in atherosclerosis: A bibliometric and visual analysis. World J Stem Cells 2024; 16(12): 1062-1085
- URL: https://www.wjgnet.com/1948-0210/full/v16/i12/1062.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i12.1062